Search
Search
Proteintech
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Immunogen sequence: MADPWQECM DYAVTLARQA GEVVCEAIKN EMNVMLKSSP VDLVTATDQK VEKMLISSIK EKYPSHSFIG EESVAAGEKS ILTDNPTWII DPIDGTTNFV HRFPFVAVSI GFAVNKKIEF GVVYSCVEGK MYTARKGKGA FCNGQKLQVS QQEDITKSLL VTELGSSRTP ETVRMVLSNM EKLFCIPVHG IRSVGTAAVN MCLVATGGAD AYYEMGIHCW DVAGAGIIVT EAGGVLMDVT GGPFDLMSRR VIAANNRILA ERIAKEIQVI PLQRDDED (1-277 aa encoded by BC008381)
IMPA1, also known as Myo-inositol monophosphatase 1, is responsible for the procurement of inositol that is required for synthesis of phosphatidylinositol and polyphosphoinositides. IMPA1 exists as a homodimer and has been identified as the pharmacological target for lithium action in the brain. IMPA1 is the principal enzyme of the phosphatidyl inositol signaling pathway, and inhibition of inositol monophosphatase hydrolysis may underlie the anti-manic and anti-depressant actions of Li+. Studies indicate that a variation in the 277 codon coding region of the IMPA1 gene has not been observed in manic-depressive patients, therefore suggesting that polymorphisms or mutations in the noncoding regions of this gene may influence the lithium response in psychiatric patients.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: D-galactose 1-phosphate phosphatase; IMP 1; IMPase 1; Inositol monophosphatase 1; inositol(myo)-1(or 4)-monophosphatase 1; Inositol-1(or 4)-monophosphatase 1; Lithium-sensitive myo-inositol monophosphatase A1; myo-inositol monophosphatase 1; testicular tissue protein Li 94
基因别名: 2610002K09Rik; 2900059K10Rik; AI325909; IMP; IMPA; IMPA1; Impa1-L
UniProt ID: (Human) P29218, (Rat) P97697
Entrez Gene ID: (Human) 3612, (Rat) 83523, (Mouse) 55980